<DOC>
	<DOCNO>NCT00003019</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness chemotherapy vinblastine methotrexate treat child desmoid tumor recurrent untreatable surgery radiation therapy .</brief_summary>
	<brief_title>Vinblastine Methotrexate Treating Children With Desmoid Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Estimate efficacy toxicity vinblastine methotrexate newly diagnose recurrent desmoid tumor child good candidate treatment surgery radiation therapy . OUTLINE : Patients receive vinblastine methotrexate IV weekly 26 week , every 2 week additional 26 week . Treatment continue maximum 1 year absence unacceptable toxicity disease progression . Patients complete response receive additional 8 dos chemotherapy . Patients follow every 6 month 4 year annually thereafter . PROJECTED ACCRUAL : A total 13-25 patient accrue study .</detailed_description>
	<mesh_term>Fibromatosis , Aggressive</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven , untreated , primary desmoid tumor ( aggressive fibromatosis ) surgery and/or radiation therapy think feasible ( prior attempt surgical resection allow gross residual disease remain ) No fibroblastic lesion fibromatoses allow Recurrent desmoid tumor previously treat vinca alkaloid methotrexate chemotherapy since recurrence Measurable disease MRI PATIENT CHARACTERISTICS : Age : Under 19 time diagnosis Performance status : Not specify Life expectancy : Not specify Hematopoietic : Hemoglobin normal age WBC normal age Platelet count normal age Hepatic : Bilirubin le 1.5 time upper limit normal ( ULN ) age SGOT le 1.5 time ULN age Renal : Creatinine le 1.5 time ULN age PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>desmoid tumor</keyword>
</DOC>